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Tetramethylenedisulfotetramine (TETS) is a potent convulsant GABAA receptor blocker. Mice receiving a
lethal dose of TETS (0.15 mg/kg i.p.) are rescued from death by a high dose of diazepam (5 mg/kg i.p.)
administered shortly after the second clonic seizure (~20 min post-TETS). However, this high dose of
diazepam signiﬁcantly impairs blood pressure and mobility, and does not prevent TETS-induced neu-
roinﬂammation in the brain. We previously demonstrated that TETS alters synchronous Ca2þ oscillations
in primary mouse hippocampal neuronal cell cultures and that pretreatment with the combination of
diazepam and allopregnanolone at concentrations having negligible effects individually prevents TETS
effects on intracellular Ca2þ dynamics. Here, we show that treatment with diazepam and allopreg-
nanolone (0.1 mM) 20 min after TETS challenge normalizes synchronous Ca2þ oscillations when added in
combination but not when added singly. Similarly, doses (0.03e0.1 mg/kg i.p.) of diazepam and allo-
pregnanolone that provide minimal protection when administered singly to TETS intoxicated mice in-
crease survival from 10% to 90% when given in combination either 10 min prior to TETS or following the
second clonic seizure. This therapeutic combination has negligible effects on blood pressure or mobility.
Combined treatment with diazepam and allopregnanolone also decreases TETS-induced microglial
activation. Diazepam and allopregnanolone have distinct actions as positive allosteric modulators of
GABAA receptors that in combination enhance survival and mitigate neuropathology following TETS
intoxication without the adverse side effects associated with high dose benzodiazepines. Combination
therapy with a benzodiazepine and neurosteroid represents a novel neurotherapeutic strategy with
potentially broad application.
© 2015 Elsevier Ltd. All rights reserved.n; AlloP, allopregnanolone;
ZP, diazepam; ESA, electrical
, hematoxylin and eosin; Iba-
, intraperitoneal; SCOs, syn-
lfotetramine.
iosciences, UC Davis School of
ive, Davis, CA 95616, USA.
l Medicines, China Pharma-
a.1. Introduction
Tetramethylenedisulfotetramine (TETS) is a highly lethal
convulsant toxicant that is believed to induce seizures by blocking
GABAA receptors in the central nervous system (Banks et al., 2014).
Tens of thousands of deaths due to TETS poisoning have been
documented, primarily in China (Li et al., 2014), and there is sig-
niﬁcant concern regarding its potential use as a chemical threat
agent outside of China (Whitlow et al., 2005; Jett and Yeung, 2010).
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GABAA receptor positive modulators, including benzodiazepines
(Olsen, 1981) and neurosteroids (Belelli et al., 1989; Kokate et al.,
1994; Wieland et al., 1995; Czlonkowska et al., 2000; Singh et al.,
2010), protect against seizures induced by other GABAA receptor
antagonists, such as picrotoxin, bicuculline and pentylenetetrazol
(Meldrum and Rogawski, 2007). Experimental evidence suggests
that benzodiazepines provide some protection against TETS-
induced seizures. For example, in mice, treatment with a high
(5 mg/kg) dose of diazepam following exposure to a lethal dose of
TETS reduced seizure manifestations and prevented lethality
(Shakarjian et al., 2012; Vito et al., 2014), but did not eliminate ictal
activity in the electroencephalogram (Shakarjian et al., 2012) or
mitigate neuroinﬂammatory responses (Vito et al., 2014). Benzo-
diazepines are the standard-of-care treatment for acute seizures
and high doses of diazepam or another benzodiazepine are often
administered to humans experiencing TETS-induced seizures
(Whitlow et al., 2005). However, the few available anecdotal re-
ports indicate that benzodiazepines alone do not effectively
terminate established TETS-induced seizures in humans or prevent
subsequent neurologic deﬁcits (Barrueto et al., 2003; Chau et al.,
2005; Whitlow et al., 2005; Deng et al., 2012; Li et al., 2012).
As part of a screen to identify improved treatment approaches
for TETS intoxication, we have studied the action of GABAA receptor
positive modulators on TETS-evoked physiological responses in an
in vitro tissue culture system. Primary cultures of mouse hippo-
campal neurons exhibit synchronous Ca2þ oscillations (Cao et al.,
2012). These synchronous Ca2þ oscillations (SCOs) are dependent
upon action potentials, as they are eliminated by tetrodotoxin
(Ogura et al., 1987), and require glutamate-mediated synaptic
transmission, as they are suppressed by AMPA and to a lesser extent
by NMDA receptor antagonists (Tanaka et al., 1996; Dravid and
Murray, 2004; Cao et al., 2012). We previously reported that addi-
tion of TETS to such cultures triggers an immediate rise in intra-
cellular Ca2þ, which is followed by decrease in the frequency and an
increase in the amplitude of Ca2þ oscillations (Cao et al., 2012).
Pretreatment with diazepam (0.03e1 mM) partially counteracted
the effect of TETS, but a major reversal only occurred at the highest
concentration tested (1 mM). Similarly, allopregnanolone
(0.03e1 mM), a neurosteroid that acts as a positive allosteric
modulator of GABAA receptors (Reddy and Rogawski, 2012), also
partially mitigated the action of TETS, but a pronounced effect only
occurred at 1 mM. In contrast, pretreatment with the combination
of diazepam and allopregnanolone each at concentrations of 0.1 mM
completely blocked the action of TETS. These results raised the
possibility that diazepam and allopregnanolone act synergistically
as a treatment for TETS poisoning. In the present study we further
investigated this combination treatment, and report that diazepam
and allopregnanolone administered after TETS exposure protects
against the action of TETS on cultured hippocampal neurons and
that the synergy observed in the in vitro model extends to in vivo
therapeutic advantages in mice. We further demonstrate that the
combination does not exhibit the excessive sedation and hypo-
tension that limit treatment with high dose diazepam (Kitajima
et al., 2004).
2. Materials and methods
2.1. Chemicals
TETS was synthesized as previously described (Zolkowska et al., 2012). A ﬁnal
recrystallization step was performed to ensure no water remained in the crystals.
The ﬁnal product was estimated to be >98% pure by gas chromatography-mass
spectrometry with total ion monitoring. TETS was dissolved in 100% DMSO and
stored as stock solutions at 10 mg/ml. USP grade diazepam in 40% propylene glycol,
10% alcohol, 5% sodium benzoate and 1.5% benzyl alcohol manufactured by Hospira
was purchased from Western Medical Supply (Arcata, CA). Allopregnanolone was
synthesized by SAFC Pharma (Madison, WI) and characterized as >99% pure byHPLC. 2-Hydroxypropyl-b-cyclodextrin was from SigmaeAldrich (St Louis, MO).
Paraformaldehyde, sulfamide, hydrochloric acid, acetone, and hexane of the high-
est purity available were obtained from Thermo Fisher Scientiﬁc (Waltham, MA).
The Ca2þ ﬂuorescence dye Fluo-4 was purchased from Life Technology (Grand Is-
land, NY). GFAP antibody was from Dako Chemical (Carpentaria, CA); Iba-1 anti-
body, from Wako Chemical (Richmond, VA); and Fluoro-Jade B, from Millipore
(Billerica, MA).
2.2. Animals
Animals were maintained in facilities fully accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care, and all experiments
involving animals were carried out in accordance with the Guide for the Care and
Use of Laboratory Animals (NIH Publication No. 8023) as adopted and promulgated
by the U.S. National Institutes of Health and as approved by the Institutional Animal
Care and Use Committee of the University of California, Davis. Young adult (6e8 wk
old) male NIH Swiss mice (22e25 g) were obtained from the Animal Resource
Program, Center for Cancer Research, National Cancer Institute (Bethesda, MD) and
were housed four per cage. All animals were kept in a vivarium under controlled
environmental conditions (22e26 C; 40e50% humidity) with a normal 12 h light/
dark cycle and free access to food and water. Animals were allowed to acclimate to
the vivarium for at least 5 d prior to experimentation. Experiments were performed
during the light phase of the light/dark cycle after at least 30 min of acclimation to
the laboratory setting.
2.3. Dosing paradigm
On the day of the experiment, stock solutions of TETS were sequentially
diluted in 10% DMSO in saline at 40e60 C to a ﬁnal concentration of 0.015 mg/ml
in 10% DMSO. TETS solutions were kept at 35e36 C and administered intra-
peritoneally (i.p.) in a volume of 10 ml/kg. Stock concentrations of diazepam
(5 mg/ml) were diluted in 10% DMSO in saline to 0.01 or 0.003 mg/ml. Allo-
pregnanolone was dissolved to a stock concentration of 10 mg/ml in 40% 2-
hydroxypropyl-b-cyclodextrin in saline and further diluted in 10% DMSO in sa-
line to 0.01 and 0.003 mg/ml. In studies assessing the efﬁcacy of pretreatment
with diazepam and/or allopregnanolone, mice were injected with diazepam
(0.1 mg/kg i.p.), allopregnanolone (0.1 mg/kg i.p.) or a combination of the two
drugs (total volume of 5 ml/kg) 10 min prior to receiving TETS (0.15 mg/kg i.p.). In
studies assessing the efﬁcacy of diazepam and/or allopregnanolone when
administered after mice had been exposed to TETS, diazepam (0.03 mg/kg i.p.)
and/or allopregnanolone (0.03 mg/kg i.p.) were administered within 2 min after
the second clonic seizure. Immediately after the TETS injection, animals were
observed for 1 h for seizure behavior, and the latency to seizure onset and
duration of each seizure were recorded for each animal as previously described
(Zolkowska et al., 2012).
2.4. Measurement of Ca2þ dynamics and SCO patterns in cultured hippocampal
neurons
Primary cultures of dissociated hippocampal neurons were derived from C57BL/
6J mice of mixed sex at postnatal day 0e1 and maintained in Neurobasal medium
(Invitrogen, Life Technologies, Carlsbad, CA) supplemented with 5% fetal bovine
serum (Atlanta Biologicals, Atlanta, GA) as previously described (Cao et al., 2012).
Hippocampal neurons between 13 and 17 days in vitro (DIV) were used to investigate
TETS-induced Ca2þ responses and the inﬂuence of diazepam and allopregnanolone
singly or in combination on TETS-induced Ca2þ dysregulation. Intracellular Ca2þ
levels were measured simultaneously in all wells of a 96-well plate using FLIPRTETRA
as described previously (Cao et al., 2012). After recording the basal Ca2þ oscillations
for 2 min, TETS (3 mM) or vehicle (0.01% DMSO) were added to the cultured hip-
pocampal neurons and the response recorded for 20 min. Diazepam and allopreg-
nanolone singly or in combinationwere added 20 min after the addition of TETS and
the response recorded for an additional 20 min.
2.5. Measurement of blood pressure
Blood pressure was measured in mice using a CODA non-invasive blood
measuring system from Kent Scientiﬁc (Torrington, CT). This system employs vol-
ume pressure recording (VPR) technology to detect changes that correspond to
systolic and diastolic blood pressures. As speciﬁed by the manufacturer, the mini-
mum and maximum values that can be measured with this system are 50e150 mm.
Blood pressure below 50 mmHg does not produce sufﬁcient blood ﬂow through the
tail to obtain an accurate reading. Mice were acclimated to the restraining device for
30 min per d for 6 d to ensure a stable blood pressure baseline prior to drug
administration. Blood pressure values represent the average of 20 measurements of
30 s each with a 10 s delay between each measurement. On the day of the experi-
ment, BP measurements were initiated 5 min after drug administration to allow the
animal's BP to stabilize after the injection of the drug and to provide time for the
drugs to distribute to the brain. Data are presented as the mean blood pressure in
mm Hg.
Fig. 1. Pretreatment with low dose diazepam and allopregnanolone (AlloP) in combination but not singly protects against TETS-induced lethality. (A) Diazepam and AlloP were
administered either singly or in combination 10 min prior to injection of a lethal dose of TETS (0.15 mg/kg i.p.) and the number of clonic seizures was counted during the ﬁrst hour
following TETS injection. Effects of pre-treatment with diazepam and AlloP at 0.03 mg/kg (B, C) or 1.0 mg/kg (D, E) were evaluated for therapeutic efﬁcacy in decreasing the number
of clonic seizures (B, D) and in decreasing the number of animals that experienced tonic seizures and died (light gray bars) versus those that survived up to 24 h post-TETS injection
(black bars) (C, E). In panels B and D, bars indicate the mean ± SEM of seizure count values for 10 animals; ***signiﬁcantly different from all other treatment groups at P < 0.001
(one-way ANOVA with post hoc Tukey's test). In logistic regression analyses of the data presented in panels C and E, the Akaike Information Criterion selected a main-effects only
model as preferable to a model with a 4-level treatment group factor. No signiﬁcant differences between treatment groups were identiﬁed in the pre-treatment studies using
diazepam and AlloP at 0.03 mg/kg. In contrast, statistically signiﬁcant differences between treatment groups were identiﬁed in the pre-treatment studies using diazepam and AlloP
at 0.1 mg/kg. The adjusted odds ratios (AOR) for the incremental main effect of each two-level factor was statistically signiﬁcant: DZPþ versus DZP AOR [95% CI] ¼ 14.5 [2.3, 93.1],
P ¼ 0.005; AlloPþ versus AlloP AOR [95% CI] ¼ 9.1 [1.5, 56.0], P ¼ 0.017. Compared to vehicle alone, the combination of the main effects of DZP and AlloP signiﬁcantly increases
survival: (AOR for “DZPþ & Allo-Pþ” versus Vehicle ¼ 131.8 [5.7, 3057], P ¼ 0.002).
Table 1
Effects of pretreatment with diazepam (DZP) and allopregnanolone (AlloP), singly or in combination, on time to onset and duration of TETS-induced seizures.
Pre-TETS treatment Time to seizure onset (min) Duration of 1st seizure (s) Duration of 2nd seizure (s) Duration of 3rd seizure (s)
Vehicle 5.9 ± 1 26 ± 5 s 30 ± 4 s 30 ± 7 s
0.1 mg/kg DZP 6.5 ± 4 18 ± 6 s 32 ± 8 s 32 ± 6 s
0.1 mg/kg AlloP 8.9 ± 2 29 ± 4 s 28 ± 7 s 36 ± 4 s
0.1 mg/kg DZP þ 0.1 mg/kg AlloP 11.7 ± 7**,D 26 ± 3 s 33 ± 6 s 34 ± 5 s
**Signiﬁcantly different from TETS animals pretreated with vehicle at P < 0.01; D signiﬁcantly different from TETS animals treated with 0.1 mg/kg DZP at P < 0.05 as
determined using one-way ANOVA with post hoc Tukey's test. Data are presented as the mean ± SEM (n ¼ 10 animals per group).
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Fig. 2. TETS-induced Ca2þ dysregulation in primary cultures of mouse hippocampal
neurons is ameliorated by low concentrations of diazepam (DZP) and allopregnanolone
(AlloP) added in combination but not singly. (A) Representative traces of spontaneous
synchronous Ca2þ oscillations (SCOs) in cultured hippocampal neurons acutely
exposed to TETS (3 mM) followed ~20 min later by addition of DZP (0.1 mM) or AlloP
(0.1 mM) added singly or in combination. The combination of DZP and AlloP was more
effective than either drug alone in ameliorating the effects of TETS on (B) the frequency
of SCOs and (C) transient Ca2þ amplitudes. Data presented as the mean ± SEM. Each
data point represents at least 8 replicates (wells) and each experiment was repeated in
two independent cultures. **Signiﬁcantly different from vehicle control (white bars) at
P < 0.01. #Signiﬁcantly different from TETS alone (light gray bars) at P < 0.05;
##P < 0.01 (one-way ANOVA with post hoc Tukey's test).
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Horizontal locomotion was assessed as an indication of sedation using the open
ﬁeld test (Silverman et al., 2011; Yang et al., 2012). Mice were placed in themiddle of
an acrylic chamber (40 cm long, 40 cmwide and 20 cm high), the ﬂoor of which was
marked off into 100 cm2 (10 cm  10 cm) boxes. The number of crossings (both hind
paws crossing into a neighboring cell) was manually recorded for a duration of
2 min. The test was performed under ambient lighting conditions prior to treatment
(pretreatment performance) and 20 min following administration of vehicle or
drug(s). Data are presented as a percent of pretreatment performance.
2.7. Wire hang test
To evaluate motor function, a slight modiﬁcation of a standard wire hang test
(Crawley, 2007) was performed. Untrained mice were administered vehicle, diaz-
epam and/or allopregnanolone i.p.; 20 min later mice were individually placed in
the middle of a clean wire cage lid. The lid was gently shaken to stimulate grasping
and then rapidly inverted and suspended over the animal's home cage for 1min. The
latency to fall was recorded. Each animal was tested in three consecutive trials. The
data are presented as the mean latency time to fall in sec; animals that did not fall
were scored as 60 s.
2.8. Histological analysis of neuroinﬂammation
Mice were perfused transcardially with phosphate buffered saline followed by
4% paraformaldehyde. Brains were removed and cryoprotected with 30% sucrose
prior to cutting with a cryostat into 10 mm sagittal sections. To quantify neuronal cell
damage, sections were stained with Fluoro-Jade B, and to assess reactive gliosis and
microglial cell activation, sections were immunostained for GFAP and Iba-1,
respectively, as previously described (Zolkowska et al., 2012). Images of the hip-
pocampus and frontal cortex were obtained on an Olympus IX-81 spinning disk
confocal microscope and the area of immunoreactivity quantiﬁed using Metamorph
Advanced Software (version 7.8.1.0, Molecular Devices Sunnyvale, CA) as previously
described (Zolkowska et al., 2012). These valueswere log-transformed. All endpoints
were examined in at least 3 serial sections per animal and data were collected from
the same level of the brain across all animals.
2.9. Statistical analyses
Data regarding seizure behavior in mice, as well as data of SCOs in cultured
neurons were analyzed using one-way ANOVA (with statistical signiﬁcance set at
P < 0.05) and differences between treatment groups were identiﬁed using post hoc
Tukey's test (GraphPad, Version 5.01, Graphpad Software Inc., La Jolla, CA). Survival
data in mice were analyzed using logistic regression using Stata 13 software (Sta-
taCorp, College Station, TX) with the Akaike Information Criterion (AIC), a
parsimony-favoring measure of model goodness-of-ﬁt used to choose between a
model with only main effects for the two experimental factors (DZP versus DZP and
AlloP versus AlloP) versus a model with separate effects for each of the four treat-
ment groups (Burnham and Anderson, 2002). Histological data were also analyzed
using Stata 13. Graphics were produced using the R 3.0.1 software suite (Vienna,
Austria; package ggplot2 version 0.9.3.1 by Hadley Wickham). Because data
regarding area of immunoreactivity were performed on multiple sections from
different brain regions of each animal, mixed-effects regression models employing
repeated measures taken from the same animal were used to account for within-
animal correlations and to improve the efﬁciency of estimates. Alternative
repeated measures analysis of variance (ANOVA) methods were inappropriate due to
missing observations and to their inability to deal with count outcomes. Exploratory
analysis of the area of GFAP/Iba-1 immunoreactivity indicated a logarithmic trans-
formation of the data was required to stabilize the variance and to allow for linear
model speciﬁcation by normalizing the distribution of the outcome. Linear mixed
effects models with animal random effects were applied unless residual scatterplots
indicated that the error variancewas approximately proportional to themean. In the
latter case, Poisson mixed effects models (log link) were used. In every model,
candidate ﬁxed effects were as follows: treatment condition, brain region (cortex or
hippocampus), number of days after treatment administration, and their in-
teractions. Variable selection was performed using the AIC and Wald tests for
pairwise comparisons of interaction effects; when interaction terms were not sig-
niﬁcant the model was simpliﬁed by removing them. Glial activation data were
expressed as counts and Poisson mixed effects models were applied with variable
selection proceeding.
3. Results
3.1. Pretreatment with combined diazepam and allopregnanolone
protects against TETS-induced lethality at doses that are ineffective
singly
Previously, we demonstrated that pretreatment with a combi-
nation of diazepam and allopregnanolone was more effective than
Fig. 3. Post-exposure treatment with low dose diazepam (DZP) and allopregnanolone (AlloP) in combination but not singly protects against TETS-induced lethality. (A) Mice
injected with a lethal dose of TETS (0.15 mg/kg i.p.) were administered DZP (0.03 mg/kg i.p.) and AlloP (0.03 mg/kg i.p.) singly or in combination ~2 min after the second clonic
seizure. (B) Seizure behavior was monitored for up to 1 h post-drug administration and the number of clonic seizures per animal was scored. Data presented as the mean ± SEM
(n ¼ 10); one-way ANOVA identiﬁed no statistically signiﬁcant differences between treatment groups with respect to the number of clonic seizures. (C) The number of animals that
experienced tonic seizures and died (light gray bars) versus those that survived up to 24 h post-TETS injection (black bars). In logistic regression analyses, the Akaike Information
Criterion selected a main-effects only model as preferable to a model with a 4-level treatment group factor: AOR [95% CI] for the incremental main effect of DZP (DZPþ versus
DZP) ¼ 3.8 [0.9, 17.4], P ¼ 0.09; AOR [95% CI] for the incremental main effect of AlloP (AlloPþ versus AlloP) ¼ 8.6 [1.9, 39.3]; P ¼ 0.006. Compared to vehicle alone, the
combination of the main effects of DZP and AlloP signiﬁcantly increases survival (AOR for “DZPþ & AlloPþ” vs. vehicle ¼ 32.5 [2.8, 381.4], P ¼ 0.006).
Table 2
Effects of post-treatment with diazepam (DZP) and allopregnanolone (AlloP), singly or in combination, on time to onset and duration of TETS-induced seizures.
Post-TETS treatment Time to seizure onset (min) Duration of 1st seizure (s) Duration of 2nd seizure (s) Duration of 3rd seizure (s)
Vehicle 4.6 ± 1 21 ± 5 28 ± 7 25 ± 8
0.03 mg/kg DZP 5.7 ± 2 24 ± 8 35 ± 9 31 ± 9
0.03 mg/kg AlloP 4.4 ± 1 23 ± 2 39 ± 9 31 ± 7
0.03 mg/kg DZP þ 0.03 mg/kg AlloP 4.4 ± 1 19 ± 4 29 ± 6 28 ± 7
No statistically signiﬁcant treatment effects were identiﬁed using one-way ANOVA (P < 0.05). Data are presented as the mean ± SEM (n ¼ 10 animals per group).
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cultured mouse hippocampal neurons (Cao et al., 2012). To deter-
mine whether these in vitro observations are predictive of in vivo
results, we assessed the efﬁcacy of pretreatment with diazepam
and allopregnanolone singly or in combination in preventing death
of mice intoxicated with a lethal dose of TETS. The lethal dose of
TETS was 0.15 mg/kg i.p., as determined previously (Zolkowska
et al., 2012; Vito et al., 2014), and doses of diazepam and allo-
pregnanolone that were ineffective or partially effective when
administered singly were determined in pilot dose-range ﬁnding
studies (Fig. 1B and 1C). Mice were treated (i.p.) with vehicle (10%
DMSO in saline), 0.1 mg/kg diazepam, 0.1 mg/kg allopregnanolone,
or a combination of the two agents at these same doses 10 min
prior to i.p. injection of a lethal dose of TETS (Fig. 1A). Treatment
with diazepam or allopregnanolone alone at these doses did not
signiﬁcantly alter the number of TETS-induced clonic seizures
relative to TETS intoxicated mice treated with vehicle (Fig. 1D).
However, combined treatment with diazepam and allopreg-
nanolone signiﬁcantly decreased the number of clonic seizures
(Fig. 1D) relative to TETS-intoxicated animals pretreated with
vehicle or either drug singly. Pretreatment with the combination
signiﬁcantly increased the time to seizure onset relative to TETS
intoxicated mice treated with vehicle or with diazepam only;
however, it did not signiﬁcantly alter seizure duration (Table 1). The
percent survival at 24 h was 10% in vehicle-treated animals (Fig 1E).Diazepam alone increased survival to 30% whereas allopreg-
nanolone alone increased survival to 20%. To determine statistical
signiﬁcance, the AIC selected a main-effects only model over a
model with separate effects for each of the four treatment groups.
Each treatment signiﬁcantly incrementally enhanced survival
(Adjusted Odds Ratio (AOR) [95% CI] for main effect of DZP (DZPþ
versus DZP) ¼ 14.5 [2.3, 93.1] and for main effect of AlloP ¼ 9.1
[1.5, 56.0]. The combined treatment was more effective than either
treatment alone, increasing survival to 90%.
3.2. Combined diazepam and allopregnanolone treatment following
TETS challenge effectively mitigates TETS dysregulation of Ca2þ
dynamics in cultured neurons
The addition of TETS to cultured mouse hippocampal neurons
triggers a reproducible, concentration-dependent biphasic change
in spontaneous Ca2þ oscillations (Cao et al., 2012). The initial effect
(phase 1 response) is an acute increase in intracellular Ca2þ levels
followed by a prolonged effect (phase II response) in which the
amplitude of Ca2þ oscillations is increased but the frequency of the
Ca2þ oscillations is decreased. We previously demonstrated that
both phase I and phase II responses to TETS can be prevented by
pretreatment with a combination of diazepam and allopreg-
nanolone at low concentrations that have minimal effect when
added singly (Cao et al., 2012). Here, we examined whether adding
Fig. 4. Combined low dose diazepam (DZP) and allopregnanolone (AlloP) does not
elicit adverse side effects observed with high dose DZP treatment. Naïve mice (not
exposed to TETS) were administered DZP (0.03 mg/kg i.p.) and AlloP (0.03 mg/kg i.p.)
singly or in combination. The effects of these low dose treatments were compared to
those of high dose of DZP (5 mg/kg i.p.) on: (A) mean blood pressure as measured
using a tail cuff system (n ¼ 5 per treatment group); (B) locomotor activity as assessed
in an open ﬁeld test (n ¼ 10 per treatment group); and (C) motor function as deter-
mined using the wire hang test (n ¼ 8 per group). Data from each study are presented
as the mean ± SEM; **signiﬁcantly different from vehicle control (white bars) at
P < 0.01; ***P < 0.001; #signiﬁcantly different from high dose (5 mg/kg) DZP at P < 0.05
(one-way ANOVA with post hoc Tukey's test). D Below the detection limit of the assay.
D.A. Bruun et al. / Neuropharmacology 95 (2015) 332e342 337diazepam and allopregnanolone to cultures after TETS exposure
would restore normal patterns of synchronous Ca2þ oscillations.
Since TETS induces an acute phase I response, we quantiﬁed the
effects of diazepam and allopregnanolone on the TETS-induced
phase II response (Fig. 2A). As illustrated by representative traces
of spontaneous Ca2þ oscillations (Fig. 2A), cultures exposed to TETS
at a ﬁnal concentration of 3 mM exhibited an acute phase I response
followed by a prolonged phase II response. The addition of either
diazepam (0.1 mM) or allopregnanolone (0.1 mM) to the assay buffer
~20 min after treatment with TETS did not alter the TETS-induced
phase II response with respect to the number of Ca2þ oscillations
(Fig. 2B). When added singly, diazepam but not allopregnanolone
signiﬁcantly reduced the amplitude of Ca2þ oscillations in TETS-
treated cultures but did not fully restore Ca2þ amplitudes to
vehicle control levels (Fig. 2C). In contrast, when added in combi-
nation, these same concentrations of diazepam and allopreg-
nanolone effectively restored both the frequency (Fig. 2B) and
amplitude (Fig. 2C) of spontaneous Ca2þ oscillations to control
levels.
3.3. Post-TETS administration of combined diazepam and
allopregnanolone prevents death of TETS-intoxicated mice at doses
that are not protective when drugs are given singly
Next, we investigated the in vivo efﬁcacy of combined versus
single administration of diazepam and allopregnanolone when
administered after TETS exposure. Seizure behavior was scored for
up to 1 h post drug administration and survival was assessed 24 h
post-TETS exposure in mice injected with a lethal dose of TETS and
then administered the drugs singly or in combination within
2 min following the second clonic seizure (~20 min post-TETS,
Fig. 3A). We previously found this to be the longest therapeutic
window for preventing death in TETS-intoxicated mice using
diazepam at 5 mg/kg i.p. (Vito et al., 2014). When administered
singly or in combination, diazepam or allopregnanolone at
0.03 mg/kg i.p. had no signiﬁcant effect on the number of TETS-
induced clonic seizures (Fig. 3B) or on the time to seizure onset
and seizure duration (Table 2). The percent survival at 24 h was
20% in vehicle-treated animals (Fig 3C). Diazepam alone
increased survival to 30% whereas allopregnanolone alone
increased survival to 50%. For the logistic regression analysis of
survival at 24 h, the AIC selected a main-effects only model instead
of a model with separate effects for each of the four treatment
groups. Administration of diazepam at 0.03 mg/kg i.p. was asso-
ciated with slight and statistically insigniﬁcant incremental
enhancement of survival (AOR [95% CI] for main effect of DZP
(DZPþ versus DZP) ¼ 3.8 [0.9, 17.4]; P ¼ 0.09), whereas the
allopregnanolone incremental enhancement of survival was sta-
tistically signiﬁcant (AOR for main effect of AlloP (AlloPþ versus
AlloP) ¼ 8.6 [1.9, 39.3]; P ¼ 0.006]. The combined treatment was
more protective than either drug administered singly, increasing
survival to 90% (Fig. 3C).
3.4. Combined low dose diazepam and allopregnanolone therapy
does not cause adverse side effects associated with high dose
diazepam therapy
In our initial studies using high dose diazepam to rescue TETS-
intoxicated mice (Vito et al., 2014), we observed a pronounced
sedative/anesthetic response following diazepam treatment.
Treatment with a lower dose of diazepam in combination with a
low dose of allopregnanolone did not seem to elicit this response.
To quantify these observations, we ﬁrst used a non-invasive tail cuff
method to measure changes in blood pressure. Administration of
diazepam at 5mg/kg i.p. causedmean blood pressure to drop below
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treatment with low doses (0.03 mg/kg i.p.) of diazepam or allo-
pregnanolone singly or in combination did not change mean blood
pressure relative to control values (Fig. 4A).
In a separate cohort of mice, we assessed potential sedative or
neurologically impairing effects of drug treatment by measuring
horizontal locomotion in the open ﬁeld test and motor function
as determined using the wire hang test. Mice injected with
diazepam at 5 mg/kg i.p. exhibited signiﬁcantly reduced loco-
motor activity relative to control mice (Fig. 4B). Locomotor ac-
tivity was signiﬁcantly increased in mice administered diazepam
at the low dose of 0.03 mg/kg, i.p., relative to control mice,
whereas mobility was comparable to that of controls in mice
injected with low dose allopregnanolone (0.03 mg/kg, i.p.) singly
or in combination with low dose diazepam (Fig. 4B). Consistent
with these observations, treatment with high dose diazepam, but
not low dose diazepam or allopregnanolone administered singly
or in combination signiﬁcantly impaired performance in the wire
hang test (Fig. 4C).
3.5. Combined low dose diazepam and allopregnanolone therapy
modulates TETS-induced neuroinﬂammation
We previously observed that intoxication with sublethal or le-
thal doses of TETS causes delayed reactive astrogliosis and micro-
glial cell activation in the cortex and hippocampus (Zolkowska
et al., 2012), and that administration of high dose diazepam
(5 mg/kg i.p.) after the second clonic seizure did not prevent this
neuroinﬂammatory response to a lethal dose of TETS (Vito et al.,
2014). Here, we determined whether combinatorial therapy with
diazepam and allopregnanolone at low doses (0.03 mg/kg i.p.)
administered following the second clonic seizure altered TETS-
induced neuroinﬂammation as determined by GFAP and Iba-1
immunohistochemistry. Brains were collected at 2 or 3 d post-
TETS exposure in mice injected with a lethal dose of TETS
(0.15 mg/kg i.p.) and rescued following the second clonic seizure
with either a single high dose of diazepam (5 mg/kg i.p.) or a
combination of low dose diazepam and allopregnanolone (each at
0.03 mg/kg i.p.). Similar to our earlier reports (Zolkowska et al.,Fig. 5. TETS-intoxicated mice rescued with high dose diazepam (DZP) or combined low dose
Representative photomicrographs of hematoxylin and eosin (H&E) staining of the frontal c
(0.15 mg/kg i.p.) then rescued from death by high dose DZP (5 mg/kg i.p.) or combined low
second clonic seizure. No gross pathological abnormalities were noted on the H&E stained2012; Vito et al., 2014), there were no gross pathological lesions
or neurodegeneration in the cortex or hippocampus of mice
rescued from TETS lethality by high dose diazepam or combined
low dose diazepam and allopregnanolone as indicated by H&E
staining (Fig. 5) and Fluoro-Jade B staining (data not shown). GFAP
immunoreactive cells were observed in the hippocampus and
cortex of TETS-intoxicated mice regardless of post-exposure treat-
ment (Fig. 6). Calculation of the geometric mean ratio (GMR) of the
area of GFAP immunoreactivity in TETS-intoxicated mice rescued
with combined low dose diazepam and allopregnanolone relative
to that of TETS-intoxicated mice rescued with high dose diazepam
revealed a signiﬁcant 3-fold and 6-fold increase in reactive astro-
gliosis in the cortex at 2 and 3 d post-TETS exposure, respectively
(Fig. 6). In the hippocampus, the area of GFAP immunoreactivity
was not signiﬁcantly different between treatment groups at 2 d
post-TETS exposure, but was increased approximately 1.5 fold in
TETS-intoxicated animals receiving the combinatorial therapy
relative to the high dose diazepam treatment group at 3 d post-
exposure (Fig. 6).
To assess microglial activation, we quantiﬁed the area of Iba-1
immunoreactivity in the cortex and hippocampus at 2 and 3 d
post-TETS exposure. Iba-1 immunoreactive cells were observed in
both brain regions in all treatment groups (Fig. 7). Calculation of the
GMR of the area of Iba-1 immunoreactivity in TETS-intoxicated
mice rescued with combined low dose diazepam and allopreg-
nanolone versus TETS-intoxicated mice rescued with high dose
diazepam indicates that the combinatorial therapy signiﬁcantly
decreases microglial activation relative to the high dose diazepam
treatment group in both brain regions at 2 and 3 d post-TETS
exposure (Fig. 7).
4. Discussion
We previously reported that combined pretreatment with low
(0.1 mM) concentrations of diazepam and allopregnanolone mark-
edly reduces TETS-induced Ca2þ dysregulation in mouse hippo-
campal cultures whereas each agent alone at the same
concentration is only minimally effective (Cao et al., 2012). We now
conﬁrm a synergistic action of the two agents against TETS-inducedDZP and allopregnanolone (AlloP) do not exhibit gross histological changes in the brain.
ortex and hippocampus of mice injected with vehicle (saline) or a lethal dose of TETS
dose DZP (0.03 mg/kg i.p.) and AlloP (0.03 mg/kg i.p.) administered ~2 min after the
sections across all treatment groups.
Fig. 6. Combined treatment with low dose diazepam (DZP) and allopregnanolone (AlloP) increases reactive astrogliosis in TETS-intoxicated animals. Representative photomi-
crographs of GFAP immunoreactivity in the hippocampus and prefrontal cortex of vehicle (saline) and TETS-intoxicated mice treated with high dose (5 mg/kg) DZP or a combination
of low dose (0.03 mg/kg) DZP and AlloP at 3 d post-injection. The quantitative analyses of these data are represented by dot plots. Dots represent the geometric mean ratio of the
area of GFAP immunoreactivity in TETS intoxicated animals treated with combined low dose DZP and AlloP versus TETS intoxicated animals treated with high dose DZP; bars
represent 95% conﬁdence intervals (n ¼ 3e6 animals per group with 4e7 sections per brain region per animal).
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TETS typically causes a sequence of seizure signs consisting of
immobility, myoclonic body jerks, clonic seizures, and tonic sei-
zures, followed immediately by death. Neither low dose diazepam
nor allopregnanolone alone reduced the frequency of clonic sei-
zures and each had only a modest effect on survival. However,
when both agents were administered together clonic seizure fre-
quency was reduced and survival at 24 h post-TETS injection
increased signiﬁcantly from 10% to 90%. A similar synergistic action
was observed with post-exposure treatment with respect to both
Ca2þ dysregulation in hippocampal cultures and TETS-induced
lethality in mice. Interestingly, the doses of diazepam and allo-
pregnanolone required to signiﬁcantly increase survival of TETS-
intoxicated mice when administered in combination were half a
log lower when administered post-TETS (0.03 mg/kg each) versus
pre-TETS (0.1 mg/kg each). The reason(s) for the different dos-
eeresponse relationship depending on time of combinatorial drug
therapy relative to TETS exposure are not known. One possibility is
that acute TETS intoxication increases the permeability of the blood
brain barrier, which increases the delivery of the drug(s) to thebrain when administered post-TETS exposure relative to pre-TETS
exposure.
Hypotension represents a key challenge in the use of benzodi-
azepines in the treatment of status epilepticus (Treiman et al., 1998;
Fritsch et al., 2010). Accordingly, we sought to assess the impact of
the combination treatment on blood pressure. Treatment with
diazepam at 5 mg/kg, a dose which we (Vito et al., 2014) and others
(Shakarjian et al., 2012) previously demonstrated was protective
against TETS-induced lethality, markedly reduced blood pressure
whereas low doses of either diazepam or allopregnanolone did not
cause hypotension. Combination treatment also did not impact
blood pressure indicating that protection against TETS-induced
lethality can be obtained at doses that allow cardiovascular func-
tion to be fully preserved. Combination treatment also did not
affect locomotor activity or impair motor performance as assessed
by the wire hang test, indicating that protection against TETS-
induced lethality can be obtained without disruption of neuro-
logic function.
In prior studies, we reported that mice surviving TETS-induced
clonic seizures do not exhibit gross histological changes in
Fig. 7. Combined treatment with low dose diazepam (DZP) and allopregnanolone (AlloP) decreases microglial cells in the hippocampus and prefrontal cortex of TETS-intoxicated
animals. Representative photomicrographs of Iba-1 immunoreactivity in the hippocampus and prefrontal cortex of vehicle (saline) and TETS-intoxicated mice treated with high dose
(5 mg/kg) DZP or a combination of low dose (0.03 mg/kg) DZP and AlloP at 3 d post-injection. The quantitative summary of these data are represented by dot plots. Dots represent
the geometric mean ratio of the area of Iba-1 immunoreactivity in TETS intoxicated animals treated with combined low dose DZP and AlloP versus TETS intoxicated animals treated
with high dose DZP; bars represent 95% conﬁdence internals (n ¼ 3e6 animals per group with 4e7 sections per brain region per animal).
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brain architecture (Zolkowska et al., 2012; Vito et al., 2014). Simi-
larly, in the present study, no gross structural brain damage was
observed in the hippocampus or cortex of mice rescued with high
dose diazepam or combination treatment with low doses of diaz-
epam and allopregnanolone. However, GFAP immunoreactivity was
increased in these brain regions 2 and 3 days after TETS exposure,
and this increasewas greater for animals receiving the combination
treatment than for those rescued with high dose diazepam. The
increase in the area of GFAP immunoreactivity likely reﬂects
astrocyte proliferation. Our earlier work indicated that the TETS-
induced increase in GFAP is transitory because levels returned to
baseline at 7 days following exposure. The implications of this
transient astrogliosis are not known, although it might serve a role
in neuroregeneration (Liu et al., 2014). If this is the case, then our
data suggesting that combination treatment causes greater astro-
gliosis than occurs when animals are rescued with high dose
diazepam raises the possibility that the combination therapy might
allow for improved recovery. This is consistent with the observa-
tion of reduced microglial activation with combination therapy as
evidenced by decreased Iba-1 immunoreactivity in animals treatedwith the combination of low dose allopregnanolone and diazepam
relative to animals rescued with high dose diazepam. Increased
microglial activation in the animals receiving high dose diazepam
could reﬂect the increased stress of seizure activity and reduced
cerebral perfusion associated with the hypotensive effect of the
treatment. These data suggest that in addition to the lack of
negative acute impact on cardiovascular and neurological function,
combined treatment with low-dose benzodiazepine and neuro-
steroid might also reduce any long-term neurologic consequences
of TETS-induced seizures in survivors.
Interestingly, we had previously observed in mice with TETS-
induced seizures that relative to post-TETS treatment with high
dose (5 mg/kg i.p.) diazepam alone, combined treatment with high
dose diazepam and a small molecule inhibitor of soluble epoxide
hydrolase (sEH) similarly increased GFAP and decreased Iba-1
immunoreactivity compared to high dose diazepam alone (Vito
et al., 2014). Pharmacologic inhibition of sEH increases the bio-
logic half-life of epoxyeicosatrienoic acids (EETs) and this action
delays the onset of seizures triggered by GABA antagonists
(Inceoglu et al., 2013). The effects of sEH inhibition on seizures were
enhanced by allopregnanolone and partially blocked by ﬁnasteride,
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gesting that effects of EETs on GABA activity are mediated in part by
neurosteroids. The observation in the present study that combined
diazepam and allopregnanolone results in similar neuro-
inﬂammatory effects as combined diazepam and sEH inhibition is
consistent with the conclusion that neurosteroids play a role in the
action of sEH inhibitors.
How does combined treatment with a benzodiazepine and
neurosteroid, each at low dose, lead to a synergistic therapeutic
action? Benzodiazepines such as diazepam act as positive allo-
steric modulators of synaptic GABAA receptors that mediate clas-
sical phasic inhibition (Mohler et al., 2002; Olsen, 2014); they do
not affect most extrasynaptic GABAA receptors that are responsible
for tonic inhibition. Nevertheless, benzodiazepines have powerful
antiseizure activity although this activity diminishes as seizures
continue (Kapur and Macdonald, 1997). There is evidence that
extrasynaptic GABAA receptors may also play a role in seizure
control (Spigelman et al., 2002; Peng et al., 2004; Brickley and
Mody, 2012). Neurosteroids such as allopregnanolone enhance
the activity of both synaptic and extrasynaptic GABAA receptors
(Herd et al., 2007; Reddy and Rogawski, 2012). Therefore, the
combined action on synaptic and extrasynaptic GABAA receptors
could contribute to the synergy. Although both benzodiazepines
and neurosteroids increase the probability of GABAA receptor
channel opening in the presence of GABA, the two types of agents
act at different sites on the GABAA receptorechannel complex and
they act in different ways (Hosie et al., 2009; Olsen, 2014). Ben-
zodiazepines increase the frequency of channel opening (Bianchi
et al., 2009; Bianchi, 2010) whereas neurosteroids increase the
mean open channel duration and decrease the mean closed time
duration (Akk et al., 2004, 2010). Of particular importance is the
reduction in long-lived closed states of the channel. Some in-
vestigators have observed benzodiazepines to increase the single
channel conductance (Eghbali et al., 1997) whereas neurosteroids
do not change the single channel conductance or the number of
active channels (Akk et al., 2010). Little is known about the
interaction between benzodiazepines and neurosteroids at the
single channel level. However, it is well recognized that neuro-
steroids, including allopregnanolone, enhance benzodiazepine
binding to the benzodiazepine recognition site on GABAA re-
ceptors as assessed with [3H]ﬂunitrazepam binding (Majewska
et al., 1986; Gee et al., 1988; Hawkinson et al., 1994). Therefore,
intramolecular interactions within the GABAA receptor that
mutually reinforce the actions of GABA, benzodiazepine, and
neurosteroid via allosteric mechanisms might account in part for
the synergy.
In conclusion, our results demonstrate that combined treatment
with diazepam and allopregnanolone, each at low dose, protects
mice against lethal seizures induced by the convulsant toxicant
TETS, a GABAA receptor antagonist. Although the basis for the
synergistic pharmacodynamic interaction between the two allo-
steric modulators is not yet deﬁned, actions on distinct populations
of GABAA receptors and combined modulation of individual GABAA
receptors could be relevant. The observation that the dual treat-
ment protects against seizure-induced lethality without systemic
side effects indicates that a combination therapy approach might
have practical utility. Combined treatment with a GABAA receptor
modulating benzodiazepine and neurosteroid could be useful not
only for treating victims acutely intoxicated with TETS but may also
have broader applicability in seizure therapy.
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